Alnylam Pharmaceuticals, Inc.

ALNYNASDAQ Global Select·USD·Closed

ALNYNASDAQ·USD·Closed

$205.52

+0.02%

$205.52

+$0.04 (0.02%)

52W Range

3thpctl

Volume

3.15×avg

Mkt Cap

27.44BUSD

P/E

33.7TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

3thpctl

Volume

3.15×avg

Market Cap

27.44BUSD

P/E Ratio

33.7TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+65.2% / yr

Operating margin20.8%

ROIC24.4%

Financially safe

Adequate

Debt / equity0.94×

Interest coverage3.1×

Current ratio3.05×

Valuation

Unrated

P/E ratio33.7×